The name is absent



CONTENTS

ACKNOWLEDGEMENTS...................................................................................................I

1 INTRODUCTION...............................................................................................................................................1

Aim...........................................................................................................................................................................2

Cost-Effectiveness Analysis (CEA)..................................................................................................................2

Coronary Heart Disease (CHD).........................................................................................................................3

TheSWSAHS..........................................................................................................................................................4

Risk Factors..........................................................................................................................................................4

Risk Factors Used in this Analysis...................................................................................................................5

2 PREVIOUS CEAS ON NUTRITION INTERVENTIONS.............................................................................6

Weinstein and Stason (1985)...............................................................................................................................6

Kritiansen, Eggen and Thelle (1991)................................................................................................................8

Crowley, Dunt and Day (1995)..........................................................................................................................9

Hall et al (1988).................................................................................................................................................11

The Interventions in More Detail...................................................................................................................16

Some Key Issues for Each Intervention.................................................................................... 19

3 THE INTERVENTIONS.................................................................................................14

Theinterventiongroups..........................................................................................14

THE INTERVENTIONS IN MORE DETAILS...........................................................................16

4 COST-EFFECTIVENESS ANALYSIS...........................................................................................................21

Effectiveness......................................................................................................................................................21

Cost-effectiveness.............................................................................................................................................29

Sensitivity Analysis - Length of effectiveness...........................................................................................30

Sensitivity Analysis - Take-up rates of programs......................................................................................31

TAKE-UP RATE AMONGST GPS)...............................................................................................................................33

Summary of results...........................................................................................................................................33

5 DISCUSSION...................................................................................................................................................34

Healthy Public Policy......................................................................................................................................34

Building Partnerships.......................................................................................................................................35

Effectiveness and evidence: biomedical, clinical & social behaviour considerations.......................35

Behaviour modification....................................................................................................................................38

Portfolio Investment........................................................................................................................................40

Otherdiseases....................................................................................................................................................41

Equity...................................................................................................................................................................41

REFERENCES.....................................................................................................................................................43

Appendixa.......................................................................................................................................................54

Appendixb.......................................................................................................................................................55

Appendixc.......................................................................................................................................................65



More intriguing information

1. he Virtual Playground: an Educational Virtual Reality Environment for Evaluating Interactivity and Conceptual Learning
2. FUTURE TRADE RESEARCH AREAS THAT MATTER TO DEVELOPING COUNTRY POLICYMAKERS
3. Concerns for Equity and the Optimal Co-Payments for Publicly Provided Health Care
4. Menarchial Age of Secondary School Girls in Urban and Rural Areas of Rivers State, Nigeria
5. SOCIOECONOMIC TRENDS CHANGING RURAL AMERICA
6. The name is absent
7. The name is absent
8. Food Prices and Overweight Patterns in Italy
9. The name is absent
10. The name is absent
11. Endogenous Heterogeneity in Strategic Models: Symmetry-breaking via Strategic Substitutes and Nonconcavities
12. The name is absent
13. The Formation of Wenzhou Footwear Clusters: How Were the Entry Barriers Overcome?
14. Education and Development: The Issues and the Evidence
15. AN ECONOMIC EVALUATION OF COTTON AND PEANUT RESEARCH IN SOUTHEASTERN UNITED STATES
16. Towards a Mirror System for the Development of Socially-Mediated Skills
17. The name is absent
18. PRIORITIES IN THE CHANGING WORLD OF AGRICULTURE
19. INTERACTION EFFECTS OF PROMOTION, RESEARCH, AND PRICE SUPPORT PROGRAMS FOR U.S. COTTON
20. The name is absent